Literature DB >> 3120077

Intravitreal liposome-encapsulated trifluorothymidine in a rabbit model.

K R Liu1, G A Peyman, B Khoobehi, H Alkan, R Fiscella.   

Abstract

Two groups of albino rabbits received an intravitreal injection of liposome-encapsulated trifluorothymidine. One group underwent a clearance study using high-performance liquid chromatography. The results of this study demonstrated a prolonged vitreal drug level within the range of ID50 for many strains of herpesvirus and human cytomegalovirus (CMV) at 28 days after injection. The eyes of another group were evaluated with preoperative and postoperative indirect ophthalmoscopy, electroretinography, and histologic examination. No retinal toxicity was found.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120077     DOI: 10.1016/s0161-6420(87)33325-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Liposome-bound cyclosporine: clearance after intravitreal injection.

Authors:  A A Alghadyan; G A Peyman; B Khoobehi; S Milner; K R Liu
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

2.  Intravitreal liposome-encapsulated drugs: a preliminary human report.

Authors:  G A Peyman; H C Charles; K R Liu; B Khoobehi; M Niesman
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

3.  Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.

Authors:  Y N Hui; H C Liang; Y S Cai; B Kirchhof; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.